Da-Li Tian

541 total citations
24 papers, 447 citations indexed

About

Da-Li Tian is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Da-Li Tian has authored 24 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Da-Li Tian's work include Drug Transport and Resistance Mechanisms (5 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Da-Li Tian is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), MicroRNA in disease regulation (5 papers) and RNA modifications and cancer (5 papers). Da-Li Tian collaborates with scholars based in China. Da-Li Tian's co-authors include Ye Tian, Xu Han, Linping Hui, Xueshan Qiu, Siyang Zhang, Zeshi Cui, Xin-Jun Dong, Wenjun Jiang, Yinghui Li and Yi Ren and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Biomedicine & Pharmacotherapy.

In The Last Decade

Da-Li Tian

24 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Da-Li Tian China 11 310 198 128 50 29 24 447
Jing Zuo China 13 297 1.0× 211 1.1× 117 0.9× 59 1.2× 24 0.8× 41 454
Chenfeng Wang China 13 259 0.8× 144 0.7× 70 0.5× 58 1.2× 32 1.1× 25 387
Nicola Inzerilli Italy 5 302 1.0× 120 0.6× 99 0.8× 77 1.5× 41 1.4× 8 420
Shuzhou Chu China 13 288 0.9× 92 0.5× 92 0.7× 53 1.1× 36 1.2× 19 403
Junhao Mu China 14 333 1.1× 119 0.6× 71 0.6× 67 1.3× 28 1.0× 23 442
Yann Duchartre United States 5 369 1.2× 107 0.5× 94 0.7× 48 1.0× 27 0.9× 7 467

Countries citing papers authored by Da-Li Tian

Since Specialization
Citations

This map shows the geographic impact of Da-Li Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Da-Li Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Da-Li Tian more than expected).

Fields of papers citing papers by Da-Li Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Da-Li Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Da-Li Tian. The network helps show where Da-Li Tian may publish in the future.

Co-authorship network of co-authors of Da-Li Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Da-Li Tian. A scholar is included among the top collaborators of Da-Li Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Da-Li Tian. Da-Li Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Qian, et al.. (2019). Tip60‑siRNA regulates ABCE1 acetylation to suppress lung cancer growth via activation of the apoptotic signaling pathway. Experimental and Therapeutic Medicine. 17(4). 3195–3202. 11 indexed citations
2.
Zhang, Lei, et al.. (2017). Cerebral ischemia/reperfusion injury induces airway mucus hypersecretion in rats and activates IL-13-associated inflammatory mechanisms. Molecular Medicine Reports. 16(5). 7577–7584. 1 indexed citations
3.
Yu, Qian, Xu Han, & Da-Li Tian. (2017). Deficiency of Functional Iron-Sulfur Domains in ABCE1 Inhibits the Proliferation and Migration of Lung Adenocarcinomas By Regulating the Biogenesis of Beta-Actin In Vitro. Cellular Physiology and Biochemistry. 44(2). 554–566. 8 indexed citations
4.
Wang, Qing, et al.. (2017). MiR‐372‐3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma. Cancer Medicine. 6(6). 1323–1330. 49 indexed citations
5.
Tian, Ye, Xin Tian, Xu Han, et al.. (2016). ABCE1 plays an essential role in lung cancer progression and metastasis. Tumor Biology. 37(6). 8375–8382. 28 indexed citations
6.
Zhang, Yuqiao, et al.. (2016). Pharmacokinetic evaluation of Shenfu Injection in beagle dogs after intravenous drip administration. Acta Pharmaceutica Sinica B. 6(6). 584–592. 15 indexed citations
7.
Han, Xu, Ye Tian, & Da-Li Tian. (2016). Tumor metastatic promoter ABCE1 interacts with the cytoskeleton protein actin and increases cell motility. Oncology Reports. 35(6). 3623–3629. 9 indexed citations
8.
Tian, Ye, et al.. (2016). MicroRNA-376c suppresses non-small-cell lung cancer cell growth and invasion by targeting LRH-1-mediated Wnt signaling pathway. Biochemical and Biophysical Research Communications. 473(4). 980–986. 27 indexed citations
9.
Jiang, Wenjun, Dandan Zhang, Zhuo Wu, et al.. (2014). Long non-coding RNA BANCR promotes proliferation and migration of lung carcinoma via MAPK pathways. Biomedicine & Pharmacotherapy. 69. 90–95. 77 indexed citations
10.
Gao, Ying, Linping Hui, Chunyu Li, et al.. (2014). Overexpression of RNF146 in Non-Small Cell Lung Cancer Enhances Proliferation and Invasion of Tumors through the Wnt/β-catenin Signaling Pathway. PLoS ONE. 9(1). e85377–e85377. 33 indexed citations
11.
Gao, Ying, et al.. (2013). Expression of p114RhoGEF predicts lymph node metastasis and poor survival of squamous-cell lung carcinoma patients. Tumor Biology. 34(3). 1925–1933. 8 indexed citations
12.
Hui, Linping, Siyang Zhang, Xin-Jun Dong, et al.. (2013). Prognostic Significance of Twist and N-Cadherin Expression in NSCLC. PLoS ONE. 8(4). e62171–e62171. 86 indexed citations
13.
Ren, Yi, Yinghui Li, & Da-Li Tian. (2012). Role of the ABCE1 gene in human lung adenocarcinoma. Oncology Reports. 27(4). 965–970. 29 indexed citations
14.
Tian, Da-Li. (2012). Risk control system construction of Shenfu injection. China Journal of Chinese Materia Medica. 37(18). 2814–7. 4 indexed citations
15.
Tian, Da-Li. (2011). Expression of a New Tumor Metastasis-related Gene ABCE1 in Non-small Cell Lung Cancer and Its Significance. 1 indexed citations
16.
Yang, Xueying, Ying Liu, Zhi‐Hong Zong, & Da-Li Tian. (2009). The Rho kinase inhibitor fasudil inhibits the migratory behaviour of 95-D lung carcinoma cells. Biomedicine & Pharmacotherapy. 64(1). 58–62. 25 indexed citations
17.
Gao, Ying, et al.. (2009). Suppression of ABCE1 Leads to Decreased Cell Proliferation and Increased Apoptosis in 95-D/NCI-H446 Lung Carcinoma Cells. 36(11). 1475–1482. 3 indexed citations
18.
Gao, Ying, et al.. (2009). Suppression of <I>ABCE1</I> Leads to Decreased Cell Proliferation and Increased Apoptosis in 95-D/NCI-H446 Lung Carcinoma Cells*. PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS. 36(11). 1475–1482. 3 indexed citations
19.
Liu, Dazhi, Da-Li Tian, & Yi Ren. (2008). [Expression and clinical significance of ABCE1 in human lung adenocarcinoma].. PubMed. 30(4). 296–7. 2 indexed citations
20.
Li, Mingjiang, et al.. (2006). Screening of metastasis-related genes in small cell lung cancer by differential display. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026